You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Belumosudil

Showing 1 - 21 of 21
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Houston (Belumosudil mesylate)

Not yet recruiting
  • Multiple Myeloma
  • Belumosudil mesylate
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2023

Chronic GVHD Trial in Atlanta (Belumosudil, Rituximab)

Not yet recruiting
  • Chronic Graft Versus Host Disease
  • Atlanta, Georgia
    Northside Hospital
Sep 21, 2023

Lung Transplant Rejection Trial in Petah-Tikva (Belumosudil, Azithromycin, Placebo)

Recruiting
  • Lung Transplant Rejection
  • Belumosudil
  • +2 more
  • Petah-Tikva, Israel
    Investigational Site Number :3760001
Oct 13, 2023

Healthy Volunteers Trial in Nottingham (Part 1: Belumosudil 40 mg/mL Sequence ABFCED, Part 1: Belumosudil 40 mg/mL Sequence

Completed
  • Healthy Volunteers
  • Part 1: Belumosudil 40 mg/mL Sequence ABFCED
  • +11 more
  • Nottingham, England, United Kingdom
    Quotient Sciences
May 10, 2022

Immune System Disorder (Healthy Volunteers) Trial in Miami (Belumosudil, UGT1A1 victim drug, P-gp victim drug)

Completed
  • Immune System Disorder (Healthy Volunteers)
  • Belumosudil
  • +3 more
  • Miami, Florida
    Investigational Site Number: 8400001
Apr 11, 2023

Chronic GVHD Trial in United States (drug, procedure, other)

Not yet recruiting
  • Chronic Graft Versus Host Disease
  • Belumosudil
  • +3 more
  • Tampa, Florida
  • +4 more
Aug 10, 2023

Chronic GVHD Trial in Duarte (Belumosudil, Placebo, Prednisone)

Recruiting
  • Chronic Graft Versus Host Disease
  • Belumosudil
  • +3 more
  • Duarte, California
    City of Hope Site Number : 8400001
Nov 23, 2023

Bronchiolitis Obliterans Syndrome, Bronchiolitis Obliterans, Lung Diseases Trial in Boston (Belumosudil, Fluticasone,

Not yet recruiting
  • Bronchiolitis Obliterans Syndrome
  • +3 more
  • Belumosudil
  • +4 more
  • Boston, Massachusetts
  • +3 more
Jun 27, 2023

Chronic GVHD Trial (Belumosudil)

Not yet recruiting
  • Chronic Graft Versus Host Disease
  • Belumosudil
  • (no location specified)
Jan 5, 2023

Diffuse Cutaneous Systemic Sclerosis Trial in United States (Belumosudil)

Completed
  • Diffuse Cutaneous Systemic Sclerosis
  • Belumosudil
  • Los Angeles, California
  • +4 more
Jan 5, 2023

Bioavailability Trial in Ruddington Nottingham (Belumosudil Tablet, Belumosudil Capsule)

Completed
Has Results
  • Bioavailability
  • Belumosudil Tablet
  • Belumosudil Capsule
  • Ruddington Nottingham, United Kingdom
    Quotient Clinical Limited
May 9, 2022

End Stage Kidney Disease, Immunological Tolerance, Kidney Transplant Failure and Rejection Trial in Los Angeles (Donor CD34+,

Not yet recruiting
  • End Stage Kidney Disease
  • +3 more
  • Donor CD34+, CD3+. and belumosudil
  • Los Angeles, California
    University of California, Los Angeles
Apr 6, 2023

Chronic Graft-versus-host-disease Trial in United States (Belumosudil 200 mg QD, Belumosudil 200 mg BID, Belumosudil 400 mg QD)

Active, not recruiting
  • Chronic Graft-versus-host-disease
  • Belumosudil 200 mg QD
  • +2 more
  • Duarte, California
  • +7 more
Aug 5, 2022

Drug-drug Interaction, Autoimmune Diseases, Fibrotic Disease Trial in Ruddington (Belumosudil, Itraconazole, Rabeprazole)

Completed
Has Results
  • Drug-drug Interaction
  • +2 more
  • Belumosudil
  • +4 more
  • Ruddington, Nottingham, United Kingdom
    Quotient Sciences Ltd
May 9, 2022

Psoriasis Vulgaris Trial in Irvine (Belumosudil)

Completed
Has Results
  • Psoriasis Vulgaris
  • Belumosudil
  • Irvine, California
    UC Irvine Health, Dept of Dermatology
Mar 15, 2022

Immune System Disorder (Healthy Volunteer) Trial in Baltimore (Belumosudil mesylate, Placebo)

Completed
  • Immune System Disorder (Healthy Volunteer)
  • Belumosudil mesylate
  • Placebo
  • Baltimore, Maryland
    Investigational site
Jun 15, 2023

Immune System Disorder (Healthy Volunteer) Trial in Buffalo (Belumosudil mesylate, Placebo)

Completed
  • Immune System Disorder (Healthy Volunteer)
  • Belumosudil mesylate
  • Placebo
  • Buffalo, New York
    Investigational site
Jun 15, 2023

Immune System Disorder (Healthy Volunteer) Trial in Buffalo (Belumosudil mesylate, Placebo)

Completed
  • Immune System Disorder (Healthy Volunteer)
  • Belumosudil mesylate
  • Placebo
  • Buffalo, New York
    Investigational site
Jun 15, 2023

GVHD Trial in United States (Belumosudil (KD025))

Completed
  • Graft vs Host Disease
  • Belumosudil (KD025)
  • Duarte, California
  • +6 more
May 27, 2022

GVHD, Chronic Trial in China (BN101)

Recruiting
  • GVHD, Chronic
  • Beijing, China
  • +7 more
Apr 24, 2022

Chronic Graft-versus-host-disease Trial in United States (Belumosudil (KD025))

Recruiting
  • Chronic Graft-versus-host-disease
  • Belumosudil (KD025)
  • Birmingham, Alabama
  • +35 more
Sep 18, 2022